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Abstract
American Indians have been found to be at higher risk of type 2 diabetes (T2D) than any other
ethnic or racial groups in the United States, with an estimated prevalence rate of 33%. Given that
T2D prevalence rates amongst the American Indian population are so high, studying the complex
factors that contribute to T2D is crucial. Of particular importance to this study is identifying her-
itable effects involved in development of T2D. Epigenetic effects, heritable changes to DNA that
affect gene expression such as DNA methylation (DNAm), have been shown to be associated with
T2D phenotypes.
Studies in other subpopulations have previously identified differential DNAm at the ABCG1 gene
as being associated with T2D. ABCG1 plays a significant role in promoting cholesterol efflux, and
it has been associated with T2D and related traits. As such, we sought to determine whether those
results generalized to American Indians by assaying DNAm at ABCG1 within a sample popula-
tion of 285 American Indian participants in the Strong Heart Study (SHS). In verifying whether
there is a significant association between DNAm levels and T2D, we hypothesize that individuals
diagnosed with T2D will have higher rates of DNAm at loci in ABCG1 than individuals who do
not have T2D. Ultimately, we hope the results of this experiment can provide more insight on the
role that differential DNAm has to play in the risk and development of T2D.
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ABSTRACT 
 American Indians have been found to be at higher risk of type 2 diabetes (T2D) than any 
other ethnic or racial groups in the United States, with an estimated prevalence rate of 33%. Given 
that T2D prevalence rates amongst the American Indian population are so high, studying the 
complex factors that contribute to T2D is crucial. Of particular importance to this study is 
identifying heritable effects involved in development of T2D. Epigenetic effects, heritable changes 
to DNA that affect gene expression such as DNA methylation (DNAm), have been shown to be 
associated with T2D phenotypes. 
 Studies in other subpopulations have previously identified differential DNAm at the ABCG1 
gene as being associated with T2D. ABCG1 plays a significant role in promoting cholesterol efflux, 
and it has been associated with T2D and related traits. As such, we sought to determine whether 
those results generalized to American Indians by assaying DNAm at ABCG1 within a sample 
population of 285 American Indian participants in the Strong Heart Study (SHS). In verifying 
whether there is a significant association between DNAm levels and T2D, we hypothesize that 
individuals diagnosed with T2D will have higher rates of DNAm at loci in ABCG1 than individuals 
who do not have T2D. Ultimately, we hope the results of this experiment can provide more insight 
on the role that differential DNAm has to play in the risk and development of T2D. 
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